Well Lead Medical Co., Ltd.

Shanghai Stock Exchange 603309.SS

Well Lead Medical Co., Ltd. EBIT for the year ending December 31, 2023: USD 34.45 M

Well Lead Medical Co., Ltd. EBIT is USD 34.45 M for the year ending December 31, 2023, a 8.36% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Well Lead Medical Co., Ltd. EBIT for the year ending December 31, 2022 was USD 31.79 M, a 36.95% change year over year.
Well Lead Medical Co., Ltd. EBIT for the year ending December 31, 2021 was USD 23.21 M, a -24.66% change year over year.
Well Lead Medical Co., Ltd. EBIT for the year ending December 31, 2020 was USD 30.81 M, a 31.09% change year over year.
Well Lead Medical Co., Ltd. EBIT for the year ending December 31, 2019 was USD 23.51 M, a 112.26% change year over year.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

Shanghai Stock Exchange: 603309.SS

Well Lead Medical Co., Ltd.

CEO	Mr. Guangyuan Han
IPO Date	March 2, 2015
Location	China
Headquarters	47, Guomao Avenue South
Employees	2,622
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Well Lead Medical Co., Ltd. engages in the research, production, and sale of medical catheters in anaesthesia, urology, respiratory, and hemodialysis areas. It also provides drainage suction nutrition products. Its products are used in hospitals, in division operations, therapies, and emergency and clinical care areas. The company markets and sells its products in China, North America, Europe, and Japan. Well Lead Medical Co., Ltd. was founded in 2004 and is headquartered in Guangzhou, China.

Key trends

Past 5 years